MedPath

H. Lee Moffitt Cancer Center and Research Institute, Inc.

H. Lee Moffitt Cancer Center and Research Institute, Inc. logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Bleomycin With or Without Electroporation Therapy in Treating Patients With Stage III or Stage IV Melanoma

Phase 1
Conditions
Melanoma (Skin)
First Posted Date
2004-06-21
Last Posted Date
2013-09-17
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Registration Number
NCT00006035
Locations
🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer

Phase 2
Completed
Conditions
Head and Neck Cancer
First Posted Date
2004-06-21
Last Posted Date
2013-05-30
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Registration Number
NCT00006033
Locations
🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

Phase 2
Terminated
Conditions
Chronic Myeloproliferative Disorders
Graft Versus Host Disease
Leukemia
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes
First Posted Date
2004-06-08
Last Posted Date
2012-12-11
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Registration Number
NCT00005641
Locations
🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Treatment of Colorectal Cancer

Not Applicable
Completed
Conditions
Colorectal Cancer
Interventions
Procedure: Preoperative Endoscopy
Radiation: Technetium Tc 99m Sulfur Colloid
Procedure: Gamma Probe
Procedure: Biopsy of Sentinel Lymph Nodes
First Posted Date
2004-05-26
Last Posted Date
2012-09-25
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
17
Registration Number
NCT00005640
Locations
🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Phase II Evaluation of FTase Inhibitor (FTI)in Treatment of Advanced Multiple Myeloma

Phase 2
Completed
Conditions
Multiple Myeloma
Interventions
Drug: FTI
First Posted Date
2004-05-20
Last Posted Date
2012-10-23
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
44
Registration Number
NCT00012350
Locations
🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer

Phase 1
Terminated
Conditions
Ovarian Cancer
First Posted Date
2004-05-03
Last Posted Date
2012-09-26
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
3
Registration Number
NCT00005612
Locations
🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer

Phase 2
Terminated
Conditions
Prostate Cancer
Interventions
First Posted Date
2004-04-02
Last Posted Date
2012-09-27
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
2
Registration Number
NCT00006371
Locations
🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

R115777 in Treating Patients With Advanced Bladder Cancer

Phase 2
Completed
Conditions
Bladder Cancer
Transitional Cell Cancer of the Renal Pelvis and Ureter
First Posted Date
2004-04-02
Last Posted Date
2013-12-04
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Registration Number
NCT00006376
Locations
🇺🇸

UCSF Cancer Center and Cancer Research Institute, San Francisco, California, United States

🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer

Phase 2
Completed
Conditions
Breast Cancer
Interventions
First Posted Date
2004-04-02
Last Posted Date
2012-10-26
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
209
Registration Number
NCT00005798
Locations
🇺🇸

Florida Cancer Specialists, Fort Myers, Florida, United States

🇺🇸

Halifax Medical Center, Daytona Beach, Florida, United States

🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

ERA-923 in Treating Postmenopausal Women With Metastatic Breast Cancer

Phase 2
Conditions
Breast Cancer
First Posted Date
2004-04-02
Last Posted Date
2013-11-06
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Registration Number
NCT00006369
Locations
🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath